Forge Biologics’ $120 Million Series B Financing

Wilson Sonsini Goodrich & Rosati advised RA Capital Management on the deal.Forge Biologics, a gene therapy-focused contract development and manufacturing organization, announced the closing of a…

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here
Martina Bellini

Author: Martina Bellini

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here